These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28334745)

  • 1. Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID.
    Roca C; Motas S; Marcó S; Ribera A; Sánchez V; Sánchez X; Bertolin J; León X; Pérez J; Garcia M; Villacampa P; Ruberte J; Pujol A; Haurigot V; Bosch F
    Hum Mol Genet; 2017 Apr; 26(8):1535-1551. PubMed ID: 28334745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme Replacement Therapy for Mucopolysaccharidosis IIID using Recombinant Human α-
    Wang F; Moen DR; Sauni C; Kan SH; Li S; Le SQ; Lomenick B; Zhang X; Ekins S; Singamsetty S; Wood J; Dickson PI; Chou TF
    Mol Pharm; 2021 Jan; 18(1):214-227. PubMed ID: 33320673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes.
    Fraldi A; Hemsley K; Crawley A; Lombardi A; Lau A; Sutherland L; Auricchio A; Ballabio A; Hopwood JJ
    Hum Mol Genet; 2007 Nov; 16(22):2693-702. PubMed ID: 17725987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic basis of mucopolysaccharidosis type IIID (MIM 252940) revealed by sequencing of GNS encoding N-acetylglucosamine-6-sulfatase.
    Mok A; Cao H; Hegele RA
    Genomics; 2003 Jan; 81(1):1-5. PubMed ID: 12573255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical, histological and functional correction of mucopolysaccharidosis type IIIB by intra-cerebrospinal fluid gene therapy.
    Ribera A; Haurigot V; Garcia M; Marcó S; Motas S; Villacampa P; Maggioni L; León X; Molas M; Sánchez V; Muñoz S; Leborgne C; Moll X; Pumarola M; Mingozzi F; Ruberte J; Añor S; Bosch F
    Hum Mol Genet; 2015 Apr; 24(7):2078-95. PubMed ID: 25524704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of bone marrow transplant, intracranial AAV-mediated gene therapy, or both in the mouse model of MPS IIIB.
    Heldermon CD; Ohlemiller KK; Herzog ED; Vogler C; Qin E; Wozniak DF; Tan Y; Orrock JL; Sands MS
    Mol Ther; 2010 May; 18(5):873-80. PubMed ID: 20179679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sanfilippo syndrome type D: natural history and identification of 3 novel mutations in the GNS Gene.
    Jansen AC; Cao H; Kaplan P; Silver K; Leonard G; De Meirleir L; Lissens W; Liebaers I; Veilleux M; Andermann F; Hegele RA; Andermann E
    Arch Neurol; 2007 Nov; 64(11):1629-34. PubMed ID: 17998446
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Marcó S; Haurigot V; Bosch F
    Hum Gene Ther; 2019 Oct; 30(10):1211-1221. PubMed ID: 31482754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy.
    Holley RJ; Ellison SM; Fil D; O'Leary C; McDermott J; Senthivel N; Langford-Smith AWW; Wilkinson FL; D'Souza Z; Parker H; Liao A; Rowlston S; Gleitz HFE; Kan SH; Dickson PI; Bigger BW
    Brain; 2018 Jan; 141(1):99-116. PubMed ID: 29186350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming Limitations Inherent in Sulfamidase to Improve Mucopolysaccharidosis IIIA Gene Therapy.
    Chen Y; Zheng S; Tecedor L; Davidson BL
    Mol Ther; 2018 Apr; 26(4):1118-1126. PubMed ID: 29503202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel loss-of-function mutation in the GNS gene causes Sanfilippo syndrome type D.
    Elçioglu NH; Pawlik B; Colak B; Beck M; Wollnik B
    Genet Couns; 2009; 20(2):133-9. PubMed ID: 19650410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucopolysaccharidosis type IIID: 12 new patients and 15 novel mutations.
    Valstar MJ; Bertoli-Avella AM; Wessels MW; Ruijter GJ; de Graaf B; Olmer R; Elfferich P; Neijs S; Kariminejad R; Suheyl Ezgü F; Tokatli A; Czartoryska B; Bosschaart AN; van den Bos-Terpstra F; Puissant H; Bürger F; Omran H; Eckert D; Filocamo M; Simeonov E; Willems PJ; Wevers RA; Niermeijer MF; Halley DJ; Poorthuis BJ; van Diggelen OP
    Hum Mutat; 2010 May; 31(5):E1348-60. PubMed ID: 20232353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors.
    Liu G; Martins I; Wemmie JA; Chiorini JA; Davidson BL
    J Neurosci; 2005 Oct; 25(41):9321-7. PubMed ID: 16221840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of pathological accumulation of glycosaminoglycans in central nervous system and peripheral tissues of MPSIIIA mice through systemic AAV9 gene transfer.
    Ruzo A; Marcó S; García M; Villacampa P; Ribera A; Ayuso E; Maggioni L; Mingozzi F; Haurigot V; Bosch F
    Hum Gene Ther; 2012 Dec; 23(12):1237-46. PubMed ID: 22909060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Improved Adeno-Associated Virus Vector for Neurological Correction of the Mouse Model of Mucopolysaccharidosis IIIA.
    Gray AL; O'Leary C; Liao A; Agúndez L; Youshani AS; Gleitz HF; Parker H; Taylor JT; Danos O; Hocquemiller M; Palomar N; Linden RM; Henckaerts E; Holley RJ; Bigger BW
    Hum Gene Ther; 2019 Sep; 30(9):1052-1066. PubMed ID: 31020862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver production of sulfamidase reverses peripheral and ameliorates CNS pathology in mucopolysaccharidosis IIIA mice.
    Ruzo A; Garcia M; Ribera A; Villacampa P; Haurigot V; Marcó S; Ayuso E; Anguela XM; Roca C; Agudo J; Ramos D; Ruberte J; Bosch F
    Mol Ther; 2012 Feb; 20(2):254-66. PubMed ID: 22008915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of central nervous system alpha-N-acetylglucosaminidase activity and therapeutic benefits in mucopolysaccharidosis IIIB mice by a single intracisternal recombinant adeno-associated viral type 2 vector delivery.
    Fu H; DiRosario J; Kang L; Muenzer J; McCarty DM
    J Gene Med; 2010 Jul; 12(7):624-33. PubMed ID: 20603889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene delivery.
    Fu H; Samulski RJ; McCown TJ; Picornell YJ; Fletcher D; Muenzer J
    Mol Ther; 2002 Jan; 5(1):42-9. PubMed ID: 11786044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum.
    Cressant A; Desmaris N; Verot L; Bréjot T; Froissart R; Vanier MT; Maire I; Heard JM
    J Neurosci; 2004 Nov; 24(45):10229-39. PubMed ID: 15537895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous HSPC Transplantation Rescues Neuroinflammation and Ameliorates Peripheral Manifestations in the Mouse Model of Lysosomal Transmembrane Enzyme Deficiency, MPS IIIC.
    Pan X; Caillon A; Fan S; Khan S; Tomatsu S; Pshezhetsky AV
    Cells; 2024 May; 13(10):. PubMed ID: 38786099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.